Squarepoint Ops LLC Cue Biopharma, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.24 - $2.18 $72,954 - $128,258	-58,834 Reduced 50.65%	57,318 $71,000
Q1 2024 May 15, 2024	BUY	$1.77 - $3.09 $128,395 - $224,148	72,540 Added 166.33%	116,152 $219,000
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.1 $75,012 - $135,197	43,612 New	43,612 $115,000
Q1 2023 May 15, 2023	BUY	$2.41 - $3.74 $48,761 - $75,671	20,233 New	20,233 $72,000
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $293,496 - $421,638	-26,205 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $69,722 - $102,827	6,270 Added 31.45%	26,205 $328,000
Q3 2020 Nov 16, 2020	BUY	$15.05 - $23.54 $300,021 - $469,269	19,935 New	19,935 $300,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.